← SynDRA
AZD-7545
SynDRA canonical compound SYN1950695 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | PDK1 | PDK2 |
|---|
| Mechanism of action | pyruvate dehydrogenase kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- pyruvate dehydrogenase kinase inhibitor
Cross-references
Synonyms
- AZD 7545
- AZD7545
- 4-[(3-Chloro-4-{[(2r)-3,3,3-Trifluoro-2-Hydroxy-2-Methylpropanoyl]amino}phenyl)sulfonyl]-N,N-Dimethylbenzamide
- 4-{3-chloro-4-[(2R)-3,3,3-trifluoro-2-hydroxy-2-methylpropanamido]benzenesulfonyl}-N,N-dimethylbenzamide
- DTDZLJHKVNTQGZ-GOSISDBHSA-N
- 2q8g
- C19H18ClF3N2O5S
- GTPL9362
- SCHEMBL6350247
- AOB6866
- MolPort-035-395-876
- ZINC1547088
- EX-A1208
- AZD-7547
- BCP07524
- KS-00000RM2
- s7517
- 2244AH
- AZD 7545;AZD-7545
- AKOS027326647
- DB07403
- CS-1740
- NCGC00250391-07
- NCGC00250391-01
- HY-16082
Look up AZD-7545 in the interactive SynDRA portal →